Business Wire

SES Extends Global Reach of Microsoft Azure ExpressRoute with Multi-orbit Satellite Systems

9.9.2019 09:55:00 EEST | Business Wire | Press release

Share

SES today announced it will provide dedicated, private network connectivity from any vessel, airplane, enterprise, energy or government site in the world to Microsoft Azure via its unique multi-orbit satellite systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190908005042/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

SES Extends Global Reach of Microsoft Azure ExpressRoute with Multi-orbit Satellite Systems (Photo: Business Wire)

As a partner of Azure ExpressRoute, SES will provide global reach and fibre-like high-performance to Azure customers via its complete portfolio of Geostationary Earth Orbit (GEO) satellites, Medium Earth Orbit (MEO) O3b constellation, global gateway network, and core terrestrial network infrastructure around the world. SES will offer Azure customers opportunities to leverage its satellite-enabled managed services to connect locations and sites in rural, remote and underserved locations, as well as vessels and airplanes out at sea and in the skies that previously did not have access to cloud services.

In addition to its global fleet of over 50 GEO satellites, SES also delivers managed data services over its proven O3b MEO satellite system, the only successful non-geostationary orbit (NGSO) broadband constellation. SES’s 20 O3b satellites comprise the only operational system today that can deliver fibre-equivalent, MEF-certified data connectivity services, and certified cloud connectivity services. The systems’ intelligent GEO- and MEO- orbit resilience that facilitate edge compute capabilities are key enablers in the seamless integration of high-performance satellite connectivity into Microsoft’s and their customers’ sites.

In addition, Azure customers also will be able to tap into SES’s groundbreaking next-generation MEO communications system, O3b mPOWER. Launching in 2021, O3b mPOWER will deliver ten times the throughput of the existing O3b constellation with unprecedented flexibility and dynamic control to help drive global cloud adoption everywhere.

“We believe that the economic and productivity benefits of the cloud should be easily available to all enterprise, maritime and aeronautical customers as well as government organisations, regardless of location. Now, as a Microsoft Azure ExpressRoute connectivity partner, we are expanding our strategic collaboration with Microsoft and extending intelligent cloud and edge services from Azure to the most underserved end points on the planet,” said JP Hemingway, CEO of SES Networks. “As the only satellite network services provider to operate a global, multi-orbit fleet utilising an extensive fleet of GEO and MEO satellites, SES stands ready to help Azure customers connect to any site at cloud scale, supporting critical enterprise workloads and offering an end-to-end network solution for emerging AI, IoT, video content services, and future applications to come.”

Ross Ortega, Partner, Product Manager of Azure Networking, Microsoft Corp. said, “We are collaborating with SES across a range of initiatives to build upon their expertise in satellite communications and increase connectivity to critical services and applications for customers in remote and underserved areas. This new collaboration between SES and Microsoft Azure Express Route further enables us to bring Azure to any business or government site.”

SES also announced today an expanded collaboration with Microsoft to benefit from Azure’s extensive cloud and AI capabilities to deliver one of the first broadcast-grade cloud services for media delivery. This builds on the broader strategic work between SES and Microsoft, as well as their shared common vision to reach everyone with intelligent cloud, media and network solutions.

More information on Azure ExpressRoute Data Sheet available here.

Follow us on:

Social Media
Blog
Media Library

About SES

SES is the world’s leading satellite operator with over 70 satellites in two different orbits, Geostationary Orbit (GEO) and Medium Earth Orbit (MEO). It provides a diverse range of customers with global video distribution and data connectivity services through two business units: SES Video and SES Networks. SES Video reaches over 355 million TV homes, through Direct-to-Home (DTH) platforms and cable, terrestrial, and IPTV networks globally. SES Video delivers a full suite of innovative end-to-end value-added services for both linear and digital distribution, and includes the ASTRA satellite system, which has the largest DTH television reach in Europe. SES Networks provides global managed data services, connecting people in a variety of sectors including telecommunications, maritime, aeronautical, and energy, as well as governments and institutions across the world. The SES Networks portfolio includes GovSat, a 50/50 public-private partnership between SES and the Luxembourg government, and O3b, the only non-geostationary system delivering fibre-like broadband services today. Further information is available at: www.ses.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

For further information:
Suzanne Ong
Public Relations
Tel. +352 710 725 500
suzanne.ong@ses.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 20:42:00 EEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 17:19:00 EEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 17:15:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 16:00:00 EEST | Press release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 15:50:00 EEST | Press release

Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by up to 97% within two months, TP53 and KRAS mutations near undetectable. Immune activity (first six patients): STC-1010 regimen nearly quadrupled cytotoxi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye